Eph receptor tyrosine kinases are functional entry receptors for murine gammaherpesvirus 68

Anna K Großkopf1, Victor Tobiasson2, Laurie T Krug1

  • 1HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.

Plos Pathogens
|October 21, 2025
PubMed

Insights

Murine gammaherpesvirus 68 (MHV68) uses Eph receptors, like EphA4 and EphB3, for cell entry. This conserved mechanism, involving the viral gH/gL glycoprotein complex, offers new targets for vaccines and therapies against gammaherpesvirus infections.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Viral glycoproteins and cellular receptors dictate virus tropism and are key vaccine targets.
  • Eph receptor tyrosine kinases are known receptors for human gammaherpesviruses (KSHV, EBV), mediating entry via the viral gH/gL complex.
  • Murine gammaherpesvirus 68 (MHV68) serves as an in vivo model for studying early gammaherpesvirus infection events.

Purpose of the Study:

  • To investigate the interaction between the MHV68 gH/gL complex and Eph receptors.
  • To evaluate MHV68's entry mechanism using Eph receptors in a rodent model.
  • To identify potential targets for therapeutic intervention against gammaherpesvirus infections.

Main Methods:

  • Characterized the interaction of MHV68 gH/gL with EphA4 and EphB3.
  • Utilized soluble decoy receptors to assess infection reduction.
  • Employed ectopic expression of Eph receptors to test infectivity in non-permissive cells.
  • Performed targeted mutagenesis based on protein structure predictions.
  • Analyzed neutralizing antibodies targeting gH D-I.

Main Results:

  • Demonstrated direct interaction between MHV68 gH/gL and EphA4/EphB3, conserved across human and murine receptors.
  • Showed that soluble decoy Eph receptors decrease MHV68 infection of fibroblasts.
  • Confirmed EphA4 and EphB3 enable MHV68 entry into non-permissive human B cells.
  • Identified the Eph-binding domain (gH D-I) as crucial for MHV68-Eph interaction, consistent with KSHV structural motifs.
  • Found that gH D-I is a primary target for gH/gL-directed neutralizing antibodies.

Conclusions:

  • Eph receptors are novel interaction and entry receptors for MHV68.
  • The conserved entry mechanism provides a basis for in vivo studies of MHV68 infection.
  • Identified gH D-I as a key target for neutralizing antibodies, paving the way for transmission-blocking strategies.